Related references
Note: Only part of the references are listed.Loss of ARID1A in Tumor Cells Renders Selective Vulnerability to Combined Ionizing Radiation and PARP Inhibitor Therapy
Youngran Park et al.
CLINICAL CANCER RESEARCH (2019)
Molecular profiling and molecular classification of endometrioid ovarian carcinomas
Paulina Cybulska et al.
GYNECOLOGIC ONCOLOGY (2019)
Systematic characterization of BAF mutations provides insights into intracomplex synthetic lethalities in human cancers
Sandra Schick et al.
NATURE GENETICS (2019)
ARID1A promotes genomic stability through protecting telomere cohesion
Bo Zhao et al.
NATURE COMMUNICATIONS (2019)
ARID1A and PI3-kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion
Mike R. Wilson et al.
NATURE COMMUNICATIONS (2019)
Functional loss of ARID1A is tightly associated with high PD-L1 expression in gastric cancer
Young-Bae Kim et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Patient with anomalous skin pigmentation expands the phenotype of ARID2 loss-of-function disorder, a SWI/SNF-related intellectual disability
Rohan Khazanchi et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2019)
ARID1A mutant ovarian clear cell carcinoma: A clear target for synthetic lethal strategies
Joseph J. Caumanns et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2018)
BAFfling pathologies: Alterations of BAF complexes in cancer
Ophelie Arnaud et al.
CANCER LETTERS (2018)
ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade
Jianfeng Shen et al.
NATURE MEDICINE (2018)
ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors
Katrien Berns et al.
ONCOGENE (2018)
Combined treatment with PI3K inhibitor BKM120 and PARP inhibitor olaparib is effective in inhibiting the gastric cancer cells with ARID1A deficiency
Lin Yang et al.
ONCOLOGY REPORTS (2018)
ARID1A loss in cancer: Towards a mechanistic understanding
Radhika Mathur
PHARMACOLOGY & THERAPEUTICS (2018)
The ARID1A, p53 and β-Catenin statuses are strong prognosticators in clear cell and endometrioid carcinoma of the ovary and the endometrium
Marlene Heckl et al.
PLOS ONE (2018)
The Tumor Suppressor ARID1A Controls Global Transcription via Pausing of RNA Polymerase II
Marco Trizzino et al.
CELL REPORTS (2018)
Inhibition of PI3K/AKT Signaling Pathway Radiosensitizes Pancreatic Cancer Cells with ARID1A Deficiency in Vitro
Lin Yang et al.
JOURNAL OF CANCER (2018)
Genomics to immunotherapy of ovarian clear cell carcinoma: Unique opportunities for management
Katsutoshi Oda et al.
GYNECOLOGIC ONCOLOGY (2018)
Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)/SMARCA4-Mutant Cancers
Julien P. N. Papillon et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Fine-tuning of noise in gene expression with nucleosome remodeling
Melina R. Megaridis et al.
APL BIOENGINEERING (2018)
Novel poly-ADP-ribose polymerase inhibitor combination strategies in ovarian cancer
Kelly E. McCann
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2018)
FDA approves PARP inhibitor for ovarian cancer
Emily Waltz
NATURE BIOTECHNOLOGY (2017)
ARID1A-mutated ovarian cancers depend on HDAC6 activity
Benjamin G. Bitler et al.
NATURE CELL BIOLOGY (2017)
AKT inhibition is an effective treatment strategy in ARID1A-deficient gastric cancer cells
Dakeun Lee et al.
ONCOTARGETS AND THERAPY (2017)
SWI/SNF aberrations sensitize pancreatic cancer cells to DNA crosslinking agents
Jean Davidson et al.
Oncotarget (2017)
Arid1a inactivation in an Apc- and Pten-defective mouse ovarian cancer model enhances epithelial differentiation and prolongs survival
Yali Zhai et al.
JOURNAL OF PATHOLOGY (2016)
ARID1A gene mutation in ovarian and endometrial cancers
Takashi Takeda et al.
ONCOLOGY REPORTS (2016)
Loss of ARID1A Activates ANXA1, which Serves as a Predictive Biomarker for Trastuzumab Resistance
Katrien Berns et al.
CLINICAL CANCER RESEARCH (2016)
Synthetic Lethal Targeting of ARID1A-Mutant Ovarian Clear Cell Tumors with Dasatinib
Rowan E. Miller et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Chromatin remodeling gene AT-rich interactive domain-containing protein 1A suppresses gastric cancer cell proliferation by targeting PIK3CA and PDK1
Qian Zhang et al.
ONCOTARGET (2016)
Chromatin-Remodeling-Factor ARID1 B Represses Wnt/β-Catenin Signaling
Georgia Vasileiou et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2015)
SWI/SNF Chromatin Remodeling and Human Malignancies
Julien Masliah-Planchon et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 10 (2015)
Potential therapeutic targets in ARID1A-mutated cancers
Benjamin G. Bitler et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
The ARID1A pathway in ovarian clear cell and endometrioid carcinoma, contiguous endometriosis, and benign endometriosis
Gautier Chene et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2015)
Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers
Benjamin G. Bitler et al.
NATURE MEDICINE (2015)
Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling
Ronald L. Chandler et al.
NATURE COMMUNICATIONS (2015)
ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors
Jianfeng Shen et al.
CANCER DISCOVERY (2015)
A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation
Kimberly C. Wiegand et al.
BMC CANCER (2014)
The emerging roles of ARID1A in tumor suppression
Ren-Chin Wu et al.
CANCER BIOLOGY & THERAPY (2014)
SWI/SNF Factors Required for Cellular Resistance to DNA Damage Include ARID1A and ARID1B and Show Interdependent Protein Stability
Reiko Watanabe et al.
CANCER RESEARCH (2014)
Loss of ARID1A expression sensitizes cancer cells to PI3K-and AKT-inhibition
Eleftherios P. Samartzis et al.
ONCOTARGET (2014)
Pathogenesis and the Role of ARID1A Mutation in Endometriosis-related Ovarian Neoplasms
Daichi Maeda et al.
ADVANCES IN ANATOMIC PATHOLOGY (2013)
PIK3CA overexpression is a possible prognostic factor for favorable survival in ovarian clear cell carcinoma
Azusa Abe et al.
HUMAN PATHOLOGY (2013)
ARID1A Mutations and PI3K/AKT Pathway Alterations in Endometriosis and Endometriosis-Associated Ovarian Carcinomas
Eleftherios P. Samartzis et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer
Tjalling Bosse et al.
MODERN PATHOLOGY (2013)
Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy
Cigall Kadoch et al.
NATURE GENETICS (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
ARID1A Mutations in Cancer: Another Epigenetic Tumor Suppressor?
Jennifer N. Wu et al.
CANCER DISCOVERY (2013)
A Landscape of Driver Mutations in Melanoma
Eran Hodis et al.
CELL (2012)
Somatic Mutations in the Chromatin Remodeling Gene ARID1A Occur in Several Tumor Types
Sian Jones et al.
HUMAN MUTATION (2012)
Loss of ARID1A Expression Is an Early Molecular Event in Tumor Progression From Ovarian Endometriotic Cyst to Clear Cell and Endometrioid Carcinoma
Ayse Ayhan et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2012)
Loss of ARID1A-Associated Protein Expression is a Frequent Event in Clear Cell and Endometrioid Ovarian Cancers
William J. Lowery et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2012)
SWI/SNF Chromatin-remodeling Factors: Multiscale Analyses and Diverse Functions
Ghia Euskirchen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma
Michael Krauthammer et al.
NATURE GENETICS (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
ARID1A, a Factor That Promotes Formation of SWI/SNF-Mediated Chromatin Remodeling, Is a Tumor Suppressor in Gynecologic Cancers
Bin Guan et al.
CANCER RESEARCH (2011)
Dynamics of expression of ARID1A and ARID1B subunits in mouse embryos and in cells during the cell cycle
Angel Flores-Alcantar et al.
CELL AND TISSUE RESEARCH (2011)
A continuum model for tumour suppression
Alice H. Berger et al.
NATURE (2011)
Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma
Meng Li et al.
NATURE GENETICS (2011)
SWI/SNF nucleosome remodellers and cancer
Boris G. Wilson et al.
NATURE REVIEWS CANCER (2011)
Researchers find a new cancer gene and a possible link between ovarian cancer and endometriosis
[Anonymous]
WOMENS HEALTH (2010)
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
Sian Jones et al.
SCIENCE (2010)
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Kimberly C. Wiegand et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The Biology of Chromatin Remodeling Complexes
Cedric R. Clapier et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2009)
ES cell pluripotency and germ-layer formation require the SWI/SNF chromatin remodeling component BAF250a
Xiaolin Gao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Highly parallel identification of essential genes in cancer cells
Biao Luo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control
Norman G. Nagl et al.
EMBO JOURNAL (2007)
Chromatin remodeling and cancer, part II: ATP-dependent chromatin remodeling
Gang G. Wang et al.
TRENDS IN MOLECULAR MEDICINE (2007)
The p270 (ARID1A/SMARCF1) subunit of mammalian SWI/SNF-related complexes is essential for normal cell cycle arrest
NG Nagl et al.
CANCER RESEARCH (2005)
Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer
DM Dinulescu et al.
NATURE MEDICINE (2005)
The SWI/SNF complex - Chromatin and cancer
CWM Roberts et al.
NATURE REVIEWS CANCER (2004)
Large-scale characterization of HeLa cell nuclear phosphoproteins
SA Beausoleil et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Recent advances in understanding chromatin remodeling by Swi/Snf complexes
JA Martens et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2003)
β-catenin expression pattern, β-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas
G Moreno-Bueno et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2001)
What does 'chromatin remodeling' mean?
JD Aalfs et al.
TRENDS IN BIOCHEMICAL SCIENCES (2000)
Common genetic changes between endometriosis and ovarian cancer
K Obata et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2000)
Share Paper
